BRENDA SHELL: Open Payments
NPI 1588744783 · WESTMINSTER, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,860 in 91 payments from 18 companies in 2025. Trend: 2023 $1,704 · 2024 $2,432 · 2025 $1,860
Food & beverage: $1,761Education: $99
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 13 | $260 |
| Janssen Biotech, Inc. | 9 | $258 |
| Novartis Pharmaceuticals Corporation | 10 | $203 |
| UCB, Inc. | 6 | $173 |
| GENZYME CORPORATION | 10 | $156 |
| Galderma Laboratories, L.P. | 6 | $114 |
| Regeneron Healthcare Solutions, Inc. | 4 | $109 |
| Biofrontera Inc. | 4 | $86 |
| Lilly USA, LLC | 3 | $78 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 3 | $73 |
Products named: DUPIXENT, TREMFYA, Bimzelx, COSENTYX, SKYRIZI, RINVOQ, NEMLUVIO, ILUMYA.
Industry payments across MD — which companies pay providers there.
